Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$837K Buy
2,361
+19
+0.8% +$5.05K 0.03% 435
2026
Q1
$354K Buy
2,342
+275
+13% +$33.4K 0.02% 649
2025
Q4
$226K Buy
2,067
+17
+0.8% +$2.47K 0.01% 817
2025
Q3
$290K Buy
2,050
+103
+5% +$15K 0.01% 683
2025
Q2
$315K Buy
+1,947
New +$242K 0.01% 636
2024
Q4
– Sell
-2,420
Closed -$346K – 889
2024
Q3
$346K Buy
2,420
+345
+17% +$49K 0.02% 618
2024
Q2
$340K Sell
2,075
-8,425
-80% -$1.05M 0.02% 592
2024
Q1
$1.31M Buy
+10,500
New +$1.11M 0.07% 248

Other funds holding ARM

Moors & Cabot's ARM Position: Q2 2026 in Review

Moors & Cabot increased its Arm (ARM) stake by 0.81% in Q2 2026, buying an estimated $5.05K and bringing the position to 2,361 shares worth $837K. The position accounts for 0.03% of the portfolio, ranked #435.

Moors & Cabot first reported a position in ARM in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.31M in Q1 2024. 961 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

  • Moors & Cabot held 2,361 shares of Arm worth $837K as of Q2 2026.
  • Moors & Cabot bought 19 Arm shares in Q2 2026, an estimated $5.05K.
  • Arm made up 0.03% of Moors & Cabot's portfolio in Q2 2026, its #435 holding.
  • Moors & Cabot first reported a position in Arm in Q1 2024 and has held it in 8 quarters since.
  • Moors & Cabot's Arm position peaked at $1.31M in Q1 2024.
  • 961 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.